Tiger Pack Bets Big on Allergan in the Third Quarter
Managers affiliated with Julian Robertson Jr. were heavily invested in the drug giant last quarter, in one of a few departures from the mainstream hedge fund crowd over the period.
Stephen TaubDecember 11, 2015
Photo credit: Bloomberg Hedge fund firms with some sort of ties to Julian Robertson Jr.’s Tiger Management continued to bet heavily on drug giant Allergan in the third quarter, new research shows. Twenty of
To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.